Literature DB >> 8450855

Management of chronic obstructive pulmonary disease.

G T Ferguson1, R M Cherniack.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8450855     DOI： 10.1056/NEJM199304083281408

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Issues in conducting randomized controlled trials of health services research interventions in nonacademic practice settings: the case of retail pharmacies.

Authors:  Morris Weinberger; Michael D Murray; David G Marrero; Nancy Brewer; Michael Lykens; Lisa E Harris; A Jeffrey Newell; Joyce Collins; William M Tierney
Journal:  Health Serv Res       Date:  2002-08       Impact factor: 3.402

2.  Rehabilitation for people with chronic lung disease.

Authors:  M D Morgan; F H Quirk; S J Singh
Journal:  Qual Health Care       Date:  1995-12

3.  Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; H Koyama; M Tsukino; M Mishima; T Izumi
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 4.  The outpatient diagnosis and management of chronic obstructive pulmonary disease: pharmacotherapy, administration of supplemental oxygen, and smoking cessation techniques.

Authors:  R M Schapira; L F Reinke
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

Review 5.  Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

Review 6.  Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

Authors:  Julia Ae Walters; Joanne Ngie Qing Tang; Phillippa Poole; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

7.  Multiple respiratory symptoms predict quality of life in chronic lung disease: a population-based study of Australian adults.

Authors:  R E Ruffin; D H Wilson; C R Chittleborough; A M Southcott; B Smith; D J Christopher
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 8.  Physiological changes due to age. Implications for respiratory drug therapy.

Authors:  J F Morris
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

9.  One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shari A Brazinsky; Robert J Lapidus; Laurence A Weiss; Mo Ghafouri; Nora M Fagan; Theodore J Witek
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  In-home Telerehabilitation for Older Persons with Chronic Obstructive Pulmonary Disease: A Pilot Study.

Authors:  Michel Tousignant; Nicole Marquis; Catherine Pagé; Ninette Imukuze; Annie Métivier; Valérie St-Onge; Annie Tremblay
Journal:  Int J Telerehabil       Date:  2012-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.